علاج نقص الصفيحات الناجم عن الهيبارين عند الحاجة إلى التدخل التاجي عبر الجلد

References

DOI: 10.1182/bloodadvances.2018024489

• In patients with acute HIT or subacute HIT A who require PCI, the ASH guideline panel suggests treatment with bivalirudin rather than a different non-heparin anticoagulant (conditional recommendation, low certainty in the evidence).
• If bivalirudin is not available or there is a lack of institutional experience, argatroban might be a suitable substitute.